Preoperative Management of Paget’s Disease

19.

Barker DJP. The epidemiology of Paget’s disease of bone. Br Med Bull. 1984;40:396–400.PubMed

20.

Altman RD, Bloch DA, Hochberg MC, Murphy WA. Prevalence of pelvic Paget’s disease of bone in the United States. J Bone Miner Res. 2000;15(3):461–5.PubMed

21.

Mautalen C, Pumarino H, Blanco MC, Gonzalez D, Ghiringhelli G, Fromm G. Paget’s disease: the South American experience. Semin Arthritis Rheum. 1994;23:226–7.PubMed

22.

Dahniya MH. Paget’s disease of bone in Africans. Br J Radiol. 1987;60:113–6.PubMed

23.

Kumar K. Paget’s disease of bone. J Indian Med Assoc. 1986;84:316–8.PubMed

24.

Joshi SR, Ambhore S, Butala N, Putwardhan M, Kulkarni M, Pai B, et al. Paget’s disease from Western India. J Assoc Physicians India. 2006;54:535–8.PubMed

25.

Falch JA. Paget’s disease in Norway. Lancet. 1979;2:1022–3.PubMed

26.

Barker DJP. The epidemiology of Paget’s disease. Metab Bone Dis Relat. 1981;3:231–4.

27.

Takata S, Hashimoto J, Nakatsuka K, Yoshimura N, Yoh K, Ohno I, et al. Guidelines for diagnosis and management of Paget’s disease of bone in Japan. J Bone Miner Metab. 2006;24:359–67.PubMed

28.

Rosenbaum HD, Hanson DJ. Geographic variation in the prevalence of Paget’s disease of bone. Radiology. 1969;92:959–63.PubMed

29.

van Staa TP, Selby P, Leufkens HG, Lyles K, Sprafka JM, Cooper C. Incidence and natural history of Paget’s disease of bone in England and Wales. J Bone Miner Res. 2002;17:465–71.PubMed

30.

Doyle T, Gunn J, Anderson G, et al. Paget’s disease in New Zealand: evidence for declining prevalence. Bone. 2002;31:616–9.PubMed

31.

Cundy T, McAnulty K, Wattie D, Gamble G, Rutland M, Ibbertson HK. Evidence for secular changes in Paget’s disease. Bone. 1997;20:69–71.PubMed

32.

Cundy HR, Gamble G, Wattie D, Rutland M, Cundy T. Paget’s disease of bone in New Zealand: continued decline in disease severity. Calcif Tissue Int. 2004;75:358–64.PubMed

33.

Poor G, Donath J, Fornet B, Cooper C. Epidemiology of Paget’s disease in Europe: the prevalence is decreasing. J Bone Miner Res. 2006;21:1545–9.PubMed

34.

Tiegs RD, Lohse CM, Wollan PC, Melton LJ. Long-term trends in the incidence of Paget’s disease of bone. Bone. 2000;27:423–7.PubMed

35.

Rendina D, Gennari L, De Filippo G, Merlotti D, de Campora E, Fazioli F, et al. Evidence for increased clinical severity of familial and sporadic Paget’s disease of bone in Campania, southern Italy. J Bone Miner Res. 2006;21:1828–35.PubMed

36.

Cundy HR, Reid IR. Paget’s disease of bone. Clin Biochem. 2012;45:43–8.PubMed

37.

Siris ES. Epidemiological aspects of Paget’s disease: family history and relationship to other medical conditions. Semin Arthritis Rheum. 1994;23:222–5.PubMed

38.

Siris ES, Canfield RE, Jacobs TE. Paget’s disease of bone. Bull N Y Acad Med. 1980;56:285–304.PubMedCentralPubMed

39.

Morales-Piga AA, Rey-Rey JS, Corres-Gonzalez J, Garcia-Sagredo JM, Lopez-Abente G. Frequency and characteristics of familial aggregation of Paget’s disease of bone. J Bone Miner Res. 1995;10:663–70.PubMed

40.

Hocking LJ, Herbert CA, Nicholis RK, Williams F, Bennett ST, Cundy T, et al. Genome wide search in familial Paget disease of bone shows evidence of genetic heterogeneity with candidate loci on chromosomes 2q36, 10p13, and 5q35. Am J Hum Genet. 2001;69:1055–61.PubMedCentralPubMed

41.

Laurin N, Brown JP, Lemainque A, Duchesne A, Huot D, Lacourciere Y, et al. Paget disease of bone: mapping of two loci at 5q35-qter and 5q31. Am J Hum Genet. 2001;69:528–43.PubMedCentralPubMed

42.

Siris ES. Indications for medical treatment of Paget’s disease of bone. In: Singer FR, Wallach S, editors. Paget’s disease of bone: clinical assessment. Present and future therapy. New York: Elsevier; 1991. p. 44–56.

43.

Sofaer JA, Holloway SM, Emery AEH. A family study of Paget’s disease of bone. J Epidemiol Community Health. 1983;37:226–31.PubMedCentralPubMed

44.

Galbraith HJB, Evans E, Lacey J. Paget’s disease of bone. A clinical and genetic study. Postgrad Med J. 1977;53:33–9.PubMedCentralPubMed

45.

Seton M, Choi HK, Hansen MF, Sebaldt RJ, Cooper C. Analysis of environmental factors in familial versus sporadic Paget’s disease of bone—the New England Registry for Paget’s Disease of Bone. J Bone Miner Res. 2003;18:1519–24.PubMed

46.

Laurin N, Brown JP, Morissette J, Raymond V. Recurrent mutation of the gene encoding sequestosome 1 (SQSTM1/p62) in Paget disease of bone. Am J Hum Genet. 2002;70:1582–8.PubMedCentralPubMed

47.

Hocking LJ, Lucas GJA, Daroszewska A, Bennett ST, Mangion J, Cundy T, et al. Domain-specific mutations in sequestosome 1 (SQSTM1) cause familial and sporadic Paget’s disease. Hum Mol Genet. 2002;11:2735–9.PubMed

48.

Layfield R, Hocking LJ. SQSTM1 and Paget’s disease of bone. Calcif Tissue Int. 2004;75:347–57.PubMed

49.

Rea SL, Walsh JP, Layfield R, Ratajczak T, Xu J. New insights into the role of sequestosome 1/p62 mutant proteins in the pathogenesis of Paget’s disease of bone. Endocr Rev. 2013;34:501–24.PubMed

50.

Visconti MR, Langston AL, Alonso N, Goodman K, Selby PL, Fraser WD, et al. Mutations of SQSTM1 are associated with severity and clinical outcome in Paget disease of bone. J Bone Miner Res. 2010;25(11):2368–73.PubMed

51.

Hocking LJ, Lucas GJA, Daroszewska A, Cundy T, Nicholson GC, Donath J, et al. Novel UBA domain mutations of SQSTM1 in Paget’s disease of bone: genotype phenotype correlation, functional analysis, and structural consequences. J Bone Miner Res. 2004;19:1122–7.PubMed

52.

Ralston SH, Layfield R. Pathogenesis of Paget disease of bone. Calcif Tissue Int. 2012;91:97–113.PubMed

53.

Hiruma Y, Kurihara N, Subler MA, Zhou H, Boykin CS, Zhang H, et al. A SQSTM1/p62 mutation linked to Paget’s disease increases the osteoclastogenic potential of the bone microenvironment. Hum Mol Genet. 2008;17:3708–19.PubMedCentralPubMed

54.

Albagha OME, Visconti MR, Alonso N, Langston AL, Cundy T, Dargie R, et al. Genome wide association study identifies variants at the CSF1, OPTN and TNFRSF11A loci as genetic risk factors for Paget’s disease of bone. Nat Genet. 2010;42:520–4.PubMedCentralPubMed

55.

Albagha OME, Wani SE, Visconti MR, Alonso N, Goodman K, Brandi ML, et al. Genome wide association identifies three new susceptibility loci for Paget’s disease of bone. Nat Genet. 2011;43:685–9.PubMed

56.

Rebel A, Malkani K, Basle M. Anomalies nucleaires des osteoclasts de la maladie osseuse de Paget. Nouv Presse Med. 1974;3:1299–301.PubMed

57.

Mills BG, Singer FR. Nuclear inclusions in Paget’s disease of bone. Science. 1976;194:201–2.PubMed

58.

Rebel A, Malkani K, Basle M, Bregeon C. Is Paget’s disease of bone a viral infection? Calcif Tissue Res. 1997;22:283–6.

59.

Mills BG, Frausto A, Singer FR, Ohsaki Y, Demulder A, Roodman GD. Multinucleated cells formed in vitro from Paget’s bone marrow express viral antigens. Bone. 1994;15:443–8.PubMed

60.

Rebel A, Basle M, Pouplard A, Malkani K, Filmon R, Lepatezour A. Bone tissue in Paget’s disease of bone. Ultrastructure and immunocytology. Arthritis Rheum. 1980;23:1104–14.PubMed

61.

Mills BG, Singer FR, Weiner LP, Holst PA. Immunohistological demonstration of respiratory syncytial virus antigens in Paget’s disease of bone. Proc Natl Acad Sci U S A. 1981;78:1209–12.PubMedCentralPubMed

62.

Reddy SV, Singer FR, Roodman GD. Bone marrow mononuclear cells from patients with Paget’s disease contain measles virus nucleocapsid messenger ribonucleic acid that has mutations in a specific region of the sequence. J Clin Endocrinol Metab. 1995;80:2108–11.PubMed

63.

Mills BG, Singer FR, Weiner LP, Sufin SC, Stabile E, Holst P. Evidence for both respiratory syncytial virus and measles virus antigens in the osteoclasts of patients with Paget’s disease of bone. Clin Orthop Relat Res. 1984;183:303–11.PubMed

64.

Kurihara N, Reddy SV, Menaa C, Anderson D, Roodman GD. Osteoclasts expressing the measles virus nucleocapsid gene display a pagetic phenotype. J Clin Invest. 2000;105(5):607–14.PubMedCentralPubMed

65.

Gordon MT, Anderson DC, Sharpe PT. Canine distemper virus localized in bone cells of patients with Paget’s disease. Bone. 1991;12:195–201.PubMed

66.

Mee AP, Dixon JA, Hoyland JA, Davies M, Selby PL, Mawer EB. Detection of canine distemper virus in 100% of Paget’s disease samples by in situ-reverse transcriptase polymerase chain reaction. Bone. 1998;23:171–5.PubMed

67.

Helfrich MH, Hobson RP, Grabowski PS, Zurbriggen A, Cosby SL, Dickson GR, et al. A negative search for a paramyxoviral etiology of Paget’s disease of bone: molecular, immunological and ultrastructural studies in UK patients. J Bone Miner Res. 2000;15:2315–29.PubMed

68.

Matthews BG, Callon K, Afzal F, Cornish J, Reid IR, Naot D. Cells cultured from bone lesions of patients with Paget’s disease show no evidence of measles virus RNA or somatic mutations in SQSTM1. J Bone Miner Res. 2007;22(1):S281.

69.

Ralston SH, Afzal MA, Helfrich MH, Fraser WD, Gallagher JA, Mee A, et al. Multicenter blinded analysis of RT-PCR detection methods for paramyxoviruses in relation to Paget’s disease of bone. J Bone Miner Res. 2007;22:569–77.PubMed

70.

Mee AP. Paramyxoviruses and Paget’s disease: the affirmative view. Bone. 1999;24:19S.PubMed

71.

Ralston SH. Paget’s disease of bone. N Engl J Med. 2013;2:644–50.

72.

Rima BK, Gassen U, Helfrich MH, Ralston SH. The pro and con of measles virus in Paget’s disease: con. J Bone Miner Res. 2002;17:2290–2.PubMed

73.

Friedrichs WE, Reddy SV, Singer FR, Roodman GD. The pro and con of measles virus in Paget’s disease: pro. J Bone Miner Res. 2002;17:2290–3.

Only gold members can continue reading. Log In or Register to continue